Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


2025年4月19日-伢途加速器官网

July 31, 2025 - Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results July 7, 2025 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2025 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

2025年4月19日-伢途加速器官网

2025年4月19日-伢途加速器官网

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

2025年4月19日-伢途加速器官网

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
海外网络专线加速器  佛跳墙v p n官方下载  shadowerocket 免费节点  ins怎么更新vivo手机  lets 快连 永远能  hd2.one黑洞加速器下载